Increases in human T helper 2 cytokine responses to Schistosoma mansoni worm and worm-tegument antigens are induced by treatment with praziquantel

Journal of Infectious Diseases

Volumn 190, Issue 4, 2004, Pages 835-842

  Joseph, Sarah ^a   Jones, Frances M ^a   Walter, Klaudia ^a   Fulford, Anthony J ^a,f   Kimani, Gachuhi ^b   Mwatha, Joseph K ^b   Kamau, Timothy ^b   Kariuki, Henry C ^c   Kazibwe, Francis ^d   Tukahebwa, Edridah ^d   Kabatereine, Narcis B ^d   Ouma, John H ^b   Vennervald, Birgitte J ^e   Dunne, David W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c Division of Vector Borne Diseases   (Kenya)

^d Vector Control Division   (Uganda)

^e DANISH BILHARZIASIS LABORATORY   (Denmark)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; PARASITE ANTIGEN; PRAZIQUANTEL; SOLUBLE EGG ANTIGEN; SOLUBLE WORM ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SCHOOL CHILD; TH2 CELL; WORM TEGUMENT;

ADOLESCENT; ADULT; ANIMALS; ANTHELMINTICS; ANTIGENS, HELMINTH; CELLS, CULTURED; CHILD; COHORT STUDIES; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; PRAZIQUANTEL; RURAL POPULATION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SPECIES SPECIFICITY; TH2 CELLS; UGANDA;

EID: 3242762609     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/422604     Document Type: Article

References (41)

1. World Health Organization (WHO) committee. The control of schistosomiasis. WHO technical report series 830. Geneva: WHO, 1993.
2. Dunne DW, Mountford A. Resistance to infection in human and animal models. In: Mahmoud AAF, ed. Schistosomiasis. London: Imperial College Press, 2001:133-212.
3. Kabatereine NB, Vennervald BJ, Ouma JH, et al. Adult resistance to Schistosomiasis mansoni: age-dependence of reinfection remains constant in communities with diverse exposure patterns. Parasitology 1999; 118:101-5.
4. Hagan P, Wilkins HA, Blumenthal UJ, Hayes RJ, Greenwood BM. Eosinophilia and resistance to Schistosoma haematobium in man. Parasite Immunol 1985; 7:625-32.
5. Hagan P, Blumenthal UJ, Dunn D, Simpson AJ, Wilkins HA. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991; 349:243-5.
6. Rihet P, Demeure CE, Bourgois A, Prata A, Dessein AJ. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur J Immunol 1991; 21:2679-86.
7. Dunne DW, Butterworth AE, Fulford AJ, et al. Immunity after treatment of human Schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur J Immunol 1992; 22:1483-94.
8. Zhang Z, Wu H, Chen S, et al. Association between IgE antibody against soluble egg antigen and resistance to reinfection with Schistosoma japonicum. Trans R Soc Trop Med Hyg 1997; 91:606-8.
9. Medhat A, Shehata M, Bucci K, et al. Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment. J Infect Dis 1998; 178:512-9.
10. Roberts M, Butterworth AE, Kimani G, et al. Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection. Infect Immun 1993; 61:4984-93.
11. Woolhouse ME, Hagan P. Seeking the ghost of worms past. Nat Med 1999; 5:1225-7.
12. Karanja DMS, Hightower AW, Colley DG, et al. Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study. Lancet 2002; 360:592-6.
13. Fulford AJ, Butterworth AE, Ouma JH, Sturrock RF. A statistical approach to schistosome population dynamics and estimation of the life-span of Schistosoma mansoni in man. Parasitology 1995; 110:307-16.
14. Hoffmann KF, Strand M. Molecular identification of a Schistosoma mansoni tegumental protein with similarity to cytoplasmic dynein light chains. J Biol Chem 1996; 271:26117-23.
15. Dunne DW, Webster M, Smith P, et al. The isolation of a 22 kDa band after SDS-PAGE of Schistosoma mansoni adult worms and its use to demonstrate that IgE responses against the antigen(s) it contains are associated with human resistance to reinfection. Parasite Immunol 1997; 19:79-89.
16. Webster M, Fulford AJ, Braun G, et al. Human immunoglobulin E responses to a recombinant 22.6-kilodalton antigen from Schistosoma mansoni adult worms are associated with low intensities of reinfection after treatment. Infect Immun 1996; 64:4042-6.
17. Smithers SR, Hackett F, Ali PO, Simpson AJ. Protective immunization of mice against Schistosoma mansoni with purified adult worm surface membranes. Parasite Immunol 1989; 11:301-18.
18. Simpson AJG. Schistosome surface antigens: developmental expression and immunological function. Parasitol Today 1990; 6:40-5.
19. Delgado VS, Suarez DP, Cesari IM, Incani RN. Experimental chemotherapy of Schistosoma mansoni with praziquantel and oxamniquine: differential effect of single or combined formulations of drugs on various strains and on both sexes of the parasite. Parasitol Res 1992; 78:648-54.
20. Fallon PG, Smith P, Nicholls T, Modha J, Doenhoff MJ. Schistosoma mansoni: praziquantel-induced exposure of alkaline phosphatase: drug-antibody synergy which acts preferentially against female worms. Parasite Immunol 1994; 16:529-36.
21. Fallon PG, Cooper RO, Probert AJ, Doenhoff MJ. Immune-dependent chemotherapy of schistosomiasis. Parasitology 1992; 105:S41-8.
22. Fallon PG, Doenhoff MJ. Active-immunisation of mice with Schistosoma worm membranes antigens enhances efficacy of praziquantel treatment of Schistosoma mansoni. Parasite Immunol 1995; 17:261-7.
23. Jeffs SA, Hagan P, Allen R, Correa-Oliveira R, Smithers SR, Simpson AJ. Molecular cloning and characterisation of the 22-kilodalton adult Schistosoma mansoni antigen recognised by antibodies from mice protectively vaccinated with isolated tegumental surface membranes. Mol Biochem Parasitol 1991; 46:159-67.
24. Webster M, Libranda-Ramirez BD, Aligui GD, et al. The influence of sex and age on antibody isotype responses to Schistosoma mansoni and Schistosoma japonicum in human populations in Kenya and the Philippines. Parasitology 1997; 114:383-93.
25. Zwingenberger K, Irschick E, Siqueira Vergetti JG, et al. Release of interleukin 2 and γ interferon by peripheral mononuclear cells in human Schistosoma mansoni infection normalizes after chemotherapy. Scand J Immunol 1989; 30:463-71.
26. Colley DG, Barsoum IS, Dahawi HS, Gamil F, Habib M, El Alamy MA. Immune responses and immunoregulation in relation to human schistosomiasis in Egypt. III. Immunity and longitudinal studies of in vitro responsiveness after treatment. Trans R Soc Trop Med Hyg 1986; 80:952-7.
27. Grogan JL, Kremsner PG, Deelder AM, Yazdanbakhsh M. Antigen-specific proliferation and interferon-γ and interleukin-5 production are down-regulated during Schistosoma haematobium infection. J Infect Dis 1998; 177:1433-7.
28. King CL, Medhat A, Malhotra I, et al. Cytokine control of parasite-specific anergy in human urinary schistosomiasis: IL-10 modulates lymphocyte reactivity. J Immunol 1996; 156:4715-21.
29. Grogan JL, Kremsner PG, Deelder AM, Yazdanbakhsh M. The effect of anti-IL-10 on proliferation and cytokine production in human schistosomiasis: fresh versus cryopreserved cells. Parasite Immunol 1998; 20:345-9.
30. King CL, Malhotra I, Mungai P, et al. Schistosoma haematobium-induced urinary tract morbidity correlates with increased tumor necrosis factor-α and diminished interleukin-10 production. J Infect Dis 2001; 184:1176-82.
31. Grzych JM, Pearce E, Cheever A, et al. Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J Immunol 1991; 146:1322-7.
32. Maizels RM, Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol 2003; 3:733-44.
33. Harnett W, Kusel R. Increased exposure of parasite antigens at the surface of adult male Schistosoma mansoni exposed to praziquantel in vitro. Parasitology 1986; 93:401-5.
34. Redman CA, Robertson A, Fallen PG, et al. Praziquantel: an urgent and exciting challenge. Parasitol Today 1996; 12:14-20.
35. Giboda M, Smith JM. Schistosoma mansoni eggs as a target for praziquantel: efficacy of oral application in mice. J Trop Med Hyg 1994; 97:98-102.
36. + cells after chemotherapy in human Schistosoma haematobium infection. Eur J Immunol 1996; 26:1365-70.
37. van den Biggelaar AHJ, Borrman S, Kremsner P, Yazdanbakhsh M. Immune responses induced by repeated treatment do not result in protective immunity to Schistosoma haematobium: interleukin (IL)-5 and IL-10 responses. J Infect Dis 2002; 186:1474-82.
38. Abath FGC, Werkhauser RC. The tegument of Schistosoma mansoni: functional and immunological features. Parasite Immunol 1996; 18:15-20.
39. Jeffs SA, Hagan P, Allen R, Correa-Oliveira R, Smithies SR, Simpson AJ. Molecular cloning and characterisation of a 22 kilodalton adult Schistosoma antigen recognised by antibodies from mice protectively vaccinated with isolated tegumental surface membranes. Mol Biochem Parasitol 1991; 46:159-67.
40. Santiago ML, Hafalla JC, Kurtis JD, et al. Identification of the Schistosoma japonicum 22.6-kDa antigen as a major target of the human IgE response: similarity of IgE-binding epitopes to allergen peptides. Int Arch Allergy Immunol 1998; 117:94-104.
41. Hoffmann KF, Wynn TA, Dunne DW. Cytokine-mediated host responses during schistosome infections: walking the fine line between immunological control and immunopathology. Adv Parasitol 2002; 52:265-307.